A Phase 2 Safety and Efficacy Study of PRT3789 in Combination With Pembrolizumab in Patients With Advanced or Metastatic Solid Tumors and a SMARCA4 Mutation

Timothy A. Yap, MD, PhD; Martin E. Gutierrez, MD; Wade T. Iams, MD; Victor Moreno, MD, PhD; Tatiana Hernández Guerrero, MD, PhD; Guzmán Alonso, MD; Carlos A. Gomez‑Roca, MD; Sophie Postel‑Vinay, MD, PhD; Fabian Acker, MD; Anna R. Minchom, MB BCh, FRCP, MD(res); Natasha B. Leighl, MD, MMSc, FRCPC, FASCO; William F. Novotny, MD; Chris Tankersley, MSc; Megan Henry, BSN, RN; Sunhee Ro, PhD; Michael J. Chisamore, PhD; John Bridgewater, MRCP, PhD, FRCP